Engineering Selectively Targeting Antimicrobial Peptides

Annu Rev Biomed Eng. 2021 Jul 13:23:339-357. doi: 10.1146/annurev-bioeng-010220-095711. Epub 2021 Apr 14.

Abstract

The rise of antibiotic-resistant strains of bacterial pathogens has necessitated the development of new therapeutics. Antimicrobial peptides (AMPs) are a class of compounds with potentially attractive therapeutic properties, including the ability to target specific groups of bacteria. In nature, AMPs exhibit remarkable structural and functional diversity, which may be further enhanced through genetic engineering, high-throughput screening, and chemical modification strategies. In this review, we discuss the molecular mechanisms underlying AMP selectivity and highlight recent computational and experimental efforts to design selectively targeting AMPs. While there has been an extensive effort to find broadly active and highly potent AMPs, it remains challenging to design targeting peptides to discriminate between different bacteria on the basis of physicochemical properties. We also review approaches for measuring AMP activity, point out the challenges faced in assaying for selectivity, and discuss the potential for increasing AMP diversity through chemical modifications.

Keywords: antimicrobial peptides; cell selectivity; high-throughput screening; machine learning; microbiota; peptide conjugates.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Bacterial Agents
  • Antimicrobial Peptides*
  • Bacteria
  • Humans
  • Protein Engineering*

Substances

  • Anti-Bacterial Agents
  • Antimicrobial Peptides